Savara, Inc. (SVRA)
5.035
+0.20
(+4.24%)
USD |
NASDAQ |
Nov 09, 16:00
5.035
0.00 (0.00%)
After-Hours: 17:55
Savara Gross Profit (Annual) : -0.245M for Dec. 31, 2025
Gross Profit (Annual) Chart
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -0.245M |
| December 31, 2024 | -0.275M |
| December 31, 2023 | -0.175M |
| December 31, 2022 | -0.167M |
| December 31, 2021 | -0.367M |
| December 31, 2020 | 0.00 |
| December 31, 2019 | -1.01M |
| December 31, 2018 | -0.526M |
| December 31, 2017 | -0.363M |
| December 31, 2016 | 0.00 |
| December 31, 2015 | -0.146M |
| December 31, 2014 | -0.085M |
| December 31, 2013 | -0.0395M |
| Date | Value |
|---|---|
| December 31, 2012 | -0.09M |
| December 31, 2011 | -0.0376M |
| December 31, 2010 | 0.4691M |
| December 31, 2009 | 0.00 |
| December 31, 2008 | 0.00 |
| December 31, 2007 | 0.00 |
| December 31, 2006 | 0.00 |
| December 31, 2005 | 0.00 |
| December 31, 2004 | 0.00 |
| December 31, 2003 | 0.00 |
| December 31, 2002 | 0.00 |
| December 31, 2001 | 0.00 |
| December 31, 2000 | 0.00 |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Annual) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 971.62M |
| Alnylam Pharmaceuticals, Inc. | 3.032B |
| Anika Therapeutics, Inc. | 63.81M |
| Vericel Corp. | 205.60M |
| Biogen, Inc. | 6.454B |